Header

UZH-Logo

Maintenance Infos

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.


Soyka, Michael; Kranzler, Henry R; Hesselbrock, Victor; Kasper, Siegfried; Mutschler, Jochen; Möller, Hans-Jürgen (2017). Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. World Journal of Biological Psychiatry, 18(2):86-119.

Abstract

These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A-F) and five levels of recommendation (1-5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.

Abstract

These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A-F) and five levels of recommendation (1-5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.

Statistics

Citations

Dimensions.ai Metrics
42 citations in Web of Science®
50 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 10 Nov 2022
0 downloads since 12 months
Detailed statistics

Additional indexing

Contributors:WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Psychiatric University Hospital Zurich > Clinic for Psychiatry, Psychotherapy, and Psychosomatics
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Psychiatry and Mental Health
Life Sciences > Biological Psychiatry
Language:English
Date:March 2017
Deposited On:10 Nov 2022 09:52
Last Modified:27 Jun 2024 01:41
Publisher:Informa Healthcare
ISSN:1562-2975
OA Status:Closed
Publisher DOI:https://doi.org/10.1080/15622975.2016.1246752
PubMed ID:28006997